Compare ELE & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELE | SANA |
|---|---|---|
| Founded | N/A | 2018 |
| Country | Canada | United States |
| Employees | 13 | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | N/A | 2021 |
| Metric | ELE | SANA |
|---|---|---|
| Price | $22.74 | $3.14 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 217.4K | ★ 1.9M |
| Earning Date | 01-01-0001 | 06-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.24 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $150.47 | N/A |
| Revenue Next Year | $91.08 | N/A |
| P/E Ratio | $255.64 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.01 | $1.27 |
| 52 Week High | $26.96 | $6.55 |
| Indicator | ELE | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 55.53 | 28.61 |
| Support Level | $18.60 | $2.85 |
| Resistance Level | $26.96 | $3.24 |
| Average True Range (ATR) | 1.47 | 0.26 |
| MACD | -0.05 | -0.07 |
| Stochastic Oscillator | 75.28 | 4.71 |
Elemental Royalty Corp is engaged in exploration discovery, royalty generation, royalty acquisition, and strategic investments.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.